 |
Articles: General Pharma |
Prior Articles
Medtronic CFO Gary Ellis to Speak at 19th Annual Wachovia Equity Conference
Medtronic, 06/22/09
Free full text
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Cephalon, 06/22/09
Free full text
CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process that Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
CEL-SCI, 06/22/09 BioMimetic Therapeutics Announces Highlights from Annual Meeting of Stockholders
BioMimetic Therapeutics, 06/22/09 Pioneers Offer EHR Advice
HealthDataManagement, 06/22/09 Lonza's New CLB-Transfection System
Amaxa Biosystems, 06/19/09
Free full text
New biological therapy Ilaris approved in US to treat children and adults with CAPS, a serious life-long auto-inflammatory disease
Novartis, 06/19/09
Free full text
Update on Eloxatin (oxaliplatin) U.S. Patent Litigation
Sanofi-aventis, 06/19/09
Free full text
Tools for planning and coordinating development of medical countermeasures in the public sector
Drug Development Research, 06/19/09 Accelerating botulism therapeutic product development in the Department of Defense
Drug Development Research, 06/19/09 U.S. Army Botulinum Neurotoxin (BoNT) Medical Therapeutics Research Program: past accomplishments and future directions
Drug Development Research, 06/19/09 Developing technologies in biodefense research: computational drug design
Drug Development Research, 06/19/09 Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease
Expert Opinion in Pharmacotherapy, 06/19/09 Manufacturing a rapid biologic response
Drug Development Research, 06/19/09 Developing medical countermeasures: from BioShield to BARDA
Drug Development Research, 06/19/09 Conducting biodefense-related research in a highly regulated academic environment
Drug Development Research, 06/19/09 Using a systems biology approach to dissect parasite-host interactions
Drug Development Research, 06/19/09 Maximizing the use of Project Bioshield contracting opportunities
Drug Development Research, 06/19/09 HIV protease inhibitors: recent clinical trials and recommendations on use
Expert Opinion in Pharmacotherapy, 06/19/09 Smart planner: radically accelerating R and D to combat a biothreat
Drug Development Research, 06/19/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
